Zai Lab Announces First Patient Treated in Greater China in PANOVA-3 Phase III Pivotal Trial of Tumor Treating Fields in Pancreatic Cancer

By
Justin.choi
-
0
11
Zai Lab Limited announced treatment of the first patient in Greater China in the PANOVA-3 trial, a Phase III pivotal trial of Tumor Treating Fields in patients with pancreatic cancer.
[Zai Lab Limited]

Sorry, but the selected Zotpress account can't be found.

Press Release